NCT02073786

Brief Summary

Lightwand is a useful alternative device for intubation but scooping movement can induce damage and microbleeding of oral mucosa, postoperative hoarseness,sore throat. Optiscope is rigid video stylet which has camera on distal tip of device. In many previous studies, rigid video stylet has proven advantages compared with other intubating devices.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 27, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Last Updated

February 18, 2015

Status Verified

February 1, 2014

Enrollment Period

5 months

First QC Date

February 21, 2014

Last Update Submit

February 15, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary success rate of intubation

    compare primary success rate of intubation using Optiscope with lightwand intubation

    within 90 sec from insertion of device

Secondary Outcomes (5)

  • Intubation time

    within 90 seconds from insertion of device

  • postoperative complications

    During PACU stay time expected up to 1hr

  • postoperative complications

    24 hr after operation

  • hemodynamic change

    baseline and 1minute after intubation

  • number of intubation trial and scooping movements

    during intubation time, an expected average of 1minute

Study Arms (2)

Lightwand

ACTIVE COMPARATOR

Conventional lightwand intubation will performe for intubation

Device: Conventional lightwand intubation

Optiscope

EXPERIMENTAL

Rigid video stylet, manufactural named Optiscope, will perform for intubation

Device: Rigid video stylet

Interventions

Conventional lightwand intubation technique will perform during intubation

Lightwand

Rigid video stylet will inserted through endotracheal tube before induction. After induction with propofol and remifentanil using TIVA infusion pump, rocuronium 0.6mg/kg were used to facilitate intubation. After 2minutes, board-certificated anesthesiologist perform intubation using Optiscope.

Also known as: Optiscope® (Pacific Medical, Seoul, Republic of Korea)
Optiscope

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for cervical spine surgery under general anesthesia
  • aged between 20- 80 yrs

You may not qualify if:

  • Patient who disagrees to participate this study
  • Patient who has history of gastro-esophageal reflux disease, previous airway surgery, an increased risk of aspiration, coagulation disorders
  • Patient who has congenital or acquired abnormalities of the upper airway, tumours, polyps, trauma, abscesses, inflammation or foreign bodies in the upper airway

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University of Hospital

Seoul, 110-799, South Korea

RECRUITING

MeSH Terms

Conditions

Hoarseness

Condition Hierarchy (Ancestors)

Voice DisordersLaryngeal DiseasesRespiratory Tract DiseasesRespiration DisordersOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Respiratory

Study Officials

  • Hee Pyung Park, MD PhD

    Professor

    STUDY DIRECTOR
  • Eugene Kim, MD

    fellow

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hee Pyung Park, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2014

First Posted

February 27, 2014

Study Start

October 1, 2014

Primary Completion

March 1, 2015

Last Updated

February 18, 2015

Record last verified: 2014-02

Locations